Recently the media has told us that the Labour Party is considering a long journeyed return: back to the nationalisation of rail services. Some claim that this will offer better […]
Guest writers
Jane Feinmann: Is the current system of publishing clinical trials fit for purpose?
This question was the title of a meeting of the Medical Journalists’ Association last week, and, perhaps surprisingly for an audience made up almost exclusively of medical journalists, the response was […]
Michael West: Collective leadership—fundamental to creating the cultures we need in the NHS
Positivity, compassion, respect, dignity, engagement, and high quality care are key to creating the cultures we need in the NHS. And, just as importantly, we must deal decisively, consistently, and […]
Jane Parry: How many cases will it take for policymakers to realize there is a HIV problem in Hong Kong?
Announcing the most recent HIV statistics for Hong Kong yesterday, the Department of Health’s Centre for Health Protection reported 154 new cases from January to March this year. In effect, […]
Nick Rose: Severe mental illness after a natural disaster—notes from the Typhoon Haiyan area of the Philippines
The occurrence of severe mental illness doubles in the months following a mass disaster (1). But few international agencies provide the specialist help needed at this time. And too often […]
Tom Jefferson et al: EMA’s data sharing policy—towards peeping tom based medicine?
Tom Jefferson and Peter Doshi are two of the guys who battled for four years to access clinical study reports on antivirals for influenza for their Cochrane review. Here they […]
Kristy Kruithof and Mafalda Pardal: Are we entering a new era of cannabis regulation?
Throughout the world, cannabis legalisation advocates and opponents have been following the recent debates and developments in the United States (Colorado and Washington state) and Uruguay with great interest. Although […]
Joe Collier: Pfizer go home
Our house guest’s question came out of the blue. Anne, who has known me for years, suddenly asked why I had stopped railing against the pharmaceutical industry. Were the companies […]
Anujeet Panesar on playing the patient
Having the fortune of being a healthy person so far, I have rarely needed to see my GP. Hence I already suspected my own experience as a patient would be […]
Jocalyn Clark: Global health in medical journals
Last week in London we had a lively and enjoyable reunion of The BMJ’s editorial registrars. In 2002 I was registrar number 13 of the now 25 year old scheme […]